Clinical trial
A Phase IV, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy And Safety of IV Paracetamol Versus Placebo in Subjects With Postoperative Pain After Total Hip Arthroplasty
NCT00344045 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IV, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Analgesic Efficacy And Safety of IV Paracetamol Versus Placebo in Subjects With Postoperative Pain After Total Hip Arthroplasty
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- February 29, 2008
- Enrollment
- 86 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.